Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Feb 1;329 ( Pt 3)(Pt 3):689-98.
doi: 10.1042/bj3290689.

Analysis of the combined effect of two linear inhibitors on a single enzyme

Affiliations

Analysis of the combined effect of two linear inhibitors on a single enzyme

J J Martinez-Irujo et al. Biochem J. .

Abstract

Different methods for studying the concurrent effects of two linear inhibitors on a single enzyme have been published, including the fractional product of Webb, the Yonetani-Theorell plot or the method of Chou and Talalay. Recently the use of combination plots has also been advocated for this purpose. We have evaluated the applicability of these methods and found that most of them depend on assumptions about the mechanism of action of the inhibitors. If the mechanism of action is not completely understood, or if some assumptions about the mechanism are unfounded, the parameters obtained may be meaningless. Even if these assumptions are correct, the interaction can be advantageously measured using an alternative representation that does not require a knowledge of the inhibition constants and allows experimental data to be retrieved from the plot. In other cases it is the interpretation of the results rather than the validity of the method that is misleading. A common mistake is to take the exclusivity of the effects of two inhibitors as exclusivity of their binding. We show that this assumption is seldom justified. In any case, it is possible to decide whether the combination of two or more inhibitors is more effective than their individual use by means of isobolographic analysis, even when no information about their mechanism of action is available.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem J. 1996 Nov 15;320 ( Pt 1):17-26 - PubMed
    1. Antimicrob Agents Chemother. 1996 May;40(5):1143-7 - PubMed
    1. J Biol Chem. 1997 Jul 18;272(29):18077-81 - PubMed
    1. Biochim Biophys Acta. 1960 Aug 26;42:381-7 - PubMed
    1. Arch Biochem Biophys. 1964 Jul 20;106:243-51 - PubMed

MeSH terms